Drug details

Allocord (cord blood injectable suspension for intravenous use)

type of

Allocord (human cord blood hematopoietic progenitor cell injection) is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor cell trans plantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with dis orders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.

This drug may have the following side effects:

• shortness of breath,
• chest pain,
• nausea,
• vomiting,
• blood in the urine,
• slow heart rate,
• fever,
• chills,
• flushing,
• high blood pressure (hypertension),
• hypersensitivity reactions (bronchospasm, wheezing, skin swelling, itching, and hives),
• rigors or
• low blood oxygen,
• fast heart rate,
• changes in taste, and
• mild headache